The FDA granted emergency use approval in April for Dr. Brooks’ saliva COVID-19 test, which has been used more than 4 million times.
Dr. Brooks was a research professor at New Brunswick, N.J.-based Rutgers University and chief executive of Infinity Biologix, one of the world’s largest biorepositories operated at Rutgers where Dr. Brooks led the development of the COVID-19 saliva test.
“We cannot thank Andy enough for all he did across his career,” Gov. Phil Murphy said in a Jan. 26 statement cited by the Times, adding Dr. Brooks’ saliva test “undoubtedly saved lives.”
Dr. Brooks earned his doctorate in microbiology and immunology from the University of Rochester (N.Y.) in 2000. He died of a heart attack Jan. 23 and is survived by his wife, mother, three daughters and sister.
More articles on leadership and management:
CEOs reveal how pandemic changed their leadership
CEOs reveal biggest pandemic surprises, inspirations
Biden’s healthcare picks: 35 notes
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.